Appeals Court Keeps Merck Derivative Suit Alive
A federal appeals court panel has given a glimmer of hope to the shareholders who filed a derivative action against Merck & Co. Inc. for allegedly covering up the health risks...To view the full article, register now.
Already a subscriber? Click here to view full article